COVID-19: ImmunityBio vaccine part of ‘Operation Warp Speed’
by Press Release from Outbreak News Today on (#541PZ)
Clinical-stage, natural killer cell-based therapeutics company, NantKwest and ImmunityBio, a privately-held immunotherapy company announced ImmunityBio has been selected to participate in Operation Warp Speed, a new national program aiming to provide substantial quantities of safe, effective vaccine for Americans by January 2021. Efforts will focus on the development, testing, and large-scale manufacturing of ImmunityBio's COVID-19 [...]
The post COVID-19: ImmunityBio vaccine part of Operation Warp Speed' appeared first on Outbreak News Today.